Description
[ Sequence ] H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
[ CAS NO. ] 52232-67-4
[ Molecular Formula ] C181H291N55O51S2
[ Molecular weight ] 4117.72
[ Appearance ] White to off White powder
[ Purity(HPLC) ] ≥95.0%
COA of Teriparatide Acetate
PeptideContent: 81.22%
Acetate Content: 11.17%
TFA Content: 0.06%
Water Content: 2.47%
About Teriparatide Acetate
Teriparatide acetate, a synthetic polypeptide fragment consisting of human parathyroid hormone residues 1-34 [hPTH(1-34)], is a bone anabolic agent used to treat osteoporosis.
Teriparatide Acetate is used in postmenopausal women with osteoporosis at a high risk for fracture or with a history of osteoporotic fracture, patients with multiple risk factors for fracture, and for patients who have failed or are intolerant to other available osteoporosis therapy.
[ Storage Temperature ] 2-8℃